2009
DOI: 10.1016/j.jneuroim.2009.03.005
|View full text |Cite
|
Sign up to set email alerts
|

HLA-DRB1⁎15 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
2
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(32 citation statements)
references
References 19 publications
1
28
2
1
Order By: Relevance
“…In all of the studies using IEF with immunofixation, Expanded Disability Status Scale (EDSS)-related outcome measures were used to define clinical outcomes; one used EDSS of 4 at 10 years disease duration,15 two used EDSS 6 during follow-up16 17 and one used an increase of ≥1 EDSS point in 5 years 18. When the results were combined, 667 of 1764 (37.8%) OCB-positive patients reached the disability outcome measures specified in the study compared with 42 of 154 (27.2%) OCB-negative patients (p<0.0001, Fisher's exact test).…”
Section: Resultsmentioning
confidence: 99%
“…In all of the studies using IEF with immunofixation, Expanded Disability Status Scale (EDSS)-related outcome measures were used to define clinical outcomes; one used EDSS of 4 at 10 years disease duration,15 two used EDSS 6 during follow-up16 17 and one used an increase of ≥1 EDSS point in 5 years 18. When the results were combined, 667 of 1764 (37.8%) OCB-positive patients reached the disability outcome measures specified in the study compared with 42 of 154 (27.2%) OCB-negative patients (p<0.0001, Fisher's exact test).…”
Section: Resultsmentioning
confidence: 99%
“…39 Further, patients negative for both HLA-DRB1*15 and oligoclonal banding were 10 years younger when reaching EDSS 6 compared to those positive for both. 40 Most imaging, biologic, or surrogate markers tend to be collected as part of cross-sectional or short-term cohort studies, comprehensive reviews of which can be found elsewhere. Special mention is given to a small but valuable cohort of patients with clinically isolated syndrome (i.e., a single neurologic attack compatible with MS); 107/140 (75%) were followed for a mean of 20 years; 67/107 (63%) fulfilled diagnostic criteria for MS, and T2 lesion volume changes and gray matter atrophy (but not white matter atrophy), particularly in the first 5 years, were associated with increased disability at 20 years and development of secondary-progressive MS. 41 Relapses and disease progression: An apparent dissociation.…”
Section: Lorraine Francementioning
confidence: 99%
“…A recent metaanalysis concluded that the presence of OB was predictive of reaching disability outcomes earlier [11]. An odds-ratio of 1.96 was reported based on 4 studies using isoelectrofocusing [16][17][18][19] including one study concerning IgM OB, which is a different issue [15,20]. The results were mainly driven by a study performed retrospectively in 1488 Swedish registry patients and used unadjusted Cox-models to predict the age at attainment of an EDSS of 6.0 [19].…”
Section: Discussionmentioning
confidence: 99%